Name | STX-478 |
---|
Description | STX-478 (compound 80) is an oral CNS-penetrant allosteric mutant-selective PI3Kα inhibitor. STX-478 STX-478 shows robust and durable tumor regression and can be used in cancer research[1]. |
---|---|
Related Catalog | |
Target |
PI3Kα[1]. |
References |
[1]. JR David St Jean, et al. Urea derivatives which can be used to treat cancer. Patent WO2022265993A1. |
Molecular Formula | C16H12F5N5O2 |
---|---|
Molecular Weight | 401.29 |